Last reviewed · How we verify
hyoscine butyl bromide
At a glance
| Generic name | hyoscine butyl bromide |
|---|---|
| Also known as | buscopan, BUSCOPAN, Buscopan |
| Sponsor | Cairo University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida (NA)
- Oral Hyoscine vs. Topical EMLA vs. Placebo for Pain Reduction During Hysterosalpingography (NA)
- A Clinical Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Capsules for Preoperative Preparation in Painless Gastrointestinal Endoscopy Procedures (NA)
- Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging (NA)
- Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis (NA)
- The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic Cholecystectomy (PHASE4)
- 4FMFES-PET Imaging of Endometrial and Ovarian Cancers (PHASE1, PHASE2)
- A Study to Investigate the Analgesic Efficacy of Ibuprofen Alone and Ibuprofen Plus Hyoscine-n- Butyl Bromide in Reducing Pain of Outpatient Hysteroscopy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- hyoscine butyl bromide CI brief — competitive landscape report
- hyoscine butyl bromide updates RSS · CI watch RSS
- Cairo University portfolio CI